$JHG
Market Cap:
$JHG SEC Filings
| Filing | Filed On |
|---|---|
| 8-K | 28 Oct 2021 |
| JANUS HENDERSON GROUP PLC OWNS 10.1% OF GLOBAL BLOOD THERAPEUTICS | 12 Oct 2021 |
| JHG13D/A - AMENDMENT NO. 4 | 04 Oct 2021 |
| 13F-HR | 16 Aug 2021 |
| JANUS HENDERSON OWNS 11% OF BIOMEA | 10 Aug 2021 |
| FORM 8-K | 02 Aug 2021 |
| 10-Q | 29 Jul 2021 |
| 8-K | 29 Jul 2021 |
| FORM 8-K | 22 Jul 2021 |
| JHG13D/A - AMENDMENT NO. 3 | 19 Jul 2021 |
| SC 13G/A | 12 Jul 2021 |
| FORM 11-K | 28 Jun 2021 |
| JHG13D/A - AMENDMENT NO. 2 | 19 May 2021 |
| 13F-HR | 17 May 2021 |
| JHG13D/A - AMENDMENT NO. 1 | 12 May 2021 |
| JANUS HENDERSON GROUP PLC OWNS 17% | 10 May 2021 |
| FORM 8-K | 03 May 2021 |
| 8-K | 29 Apr 2021 |
| 10-Q | 29 Apr 2021 |
| JANUS HENDERSON GROUP PLC OWNS 10% OF NEUROCRINE | 12 Apr 2021 |
